Sitagliptin

sitagliptin · Merck & Co.

Drug timelines are a Plus or Pro feature.

182 regulatory and trial events tracked for Sitagliptin, covering 2008-06-13 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Sitagliptin in Recurrent/Progressive Grade 4 Glioma [Phase 1]